News

News about advances made possible through IPIRA's work, such as innovations commercialized, campus partnerships with industry, and companies born out of licensing UC Berkeley intellectual property rights.

All News

November 4, 2021

Scribe Therapeutics Wins 2021 Pantheon Rising Star Award

Link

November 2, 2021

Ottobock Acquires Exoskeleton Specialist suitX

Link

October 14, 2021

OneD to Build Pilot Silicon-Graphite-Anode Plant

Link

October 13, 2021

Intellia Therapeutics Collaborates with SparingVision to Develop Ocular Therapies

Link

October 12, 2021

Lucira Health COVID-19 Test Approved for Sale in Singapore

https://www.globenewswire.com/news-release/2021/10/12/2312368/0/en/LUCIR...

October 7, 2021

Self-Destructing Plastic Wins Top Prize in Create the Future Contest

Link

October 6, 2021

Intellia Phase 1/2 Clinical Trial Authorized for Hereditary Angioedema Treatment

Link

CalWave Commissions Open-water Wave Energy Pilot

Link

September 23, 2021

GenEdit Closes $26 Million in Series A Financing

Link

September 14, 2021

Ambi Robotics Announces $26 Million Series A Funding Led By Tiger Global

Link

September 9, 2021

Mammoth Biosciences Raises $195 Million, Vaulting Its Crispr Tech to Unicorn Status

Link

September 8, 2021

Contest Challenges Inventors to Harness Wave Power to Desalinate Seawater

Link

Breakthrough "Air Stable" Quantum Dot Component Enters Mass Production

Link

August 27, 2021

14 Best Berkeley Medical Device Startups Revolutionizing Healthcare

Link

August 19, 2021

Huue and Ginkgo Bioworks Partner to Accelerate Production of Sustainable Dyes

Link

August 12, 2021

AngioDynamics Receives FDA Approval for PRESERVE Study

Link

Iaterion, Inc. Awarded NIH Grant for Nuclear Receptor Coligand Platform

Link

August 11, 2021

FDA-approved Trial Evaluates AngioDynamics’ NanoKnife for Prostate Tissue Ablation

Link

July 28, 2021

Study Reveals Gene Involved in Stem Rust Resistance in Wheat

https://www.isaaa.org/kc/cropbiotechupdate/article/default.asp?ID=18918

July 23, 2021

Caribou Raises $304M in One of Gene Editing's Most Lucrative IPOs

Link